Barely Significant
← all excerpts

Pharmacological management of non-alcoholic fatty liver disease: Atorvastatin versus pentoxifylline.

Exp Ther Med · 2017 · PMC5443168 · PMID 28565851

Europe PMCDOI
2
hedged sentences
0.0407
closest p · 0.8× alpha
0.0407
boldest claim

The sentences

borderline significantP=0.04073actually significant
Group II exhibited a mean NAS score at termination of 3.98±1.48, which is borderline significant compared to the initial NAS score (P=0.04073).

also in 11,409 other papers

of marginal significanceP=0.04073actually significant
The difference in the initial and final NAS scores of patients from the non-dyslipidemic group administered pentoxifylline was of marginal significance (P=0.04073).

also in 464 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.